SEC Form 4 · accession 0001179110-18-001598
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adrian T Dillon
Director
Period of report
Feb 1, 2018
Accepted (ET)
Feb 5, 2018 · 9:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2018 | A | 1,637 | $0.00 | A | 12,328 | D | |
| Common StockF2 | Feb 1, 2018 | A | 793 | $0.00 | A | 13,121 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F5 | $50.41 | Feb 1, 2018 | A | 4,339 | A | — | Feb 1, 2028 | Common Stock | 4,339 | 4,339 | D |
| Stock Option (right to buy)F3 | $46.40 | holding | — | — | — | — | Feb 1, 2027 | Common Stock | 4,837 | 4,837 | D |
| Stock Option (right to buy)F4 | $32.50 | holding | — | — | — | — | Sep 1, 2026 | Common Stock | 7,632 | 7,632 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 818 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2019. Vested shares will be delivered to the reporting person upon vesting.
- F2Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 198 shares on February 1, 2018. The remaining restricted stock units vest as to 198 shares on May 1, 2018 and August 1, 2018, and as to 199 shares on November 1, 2018. Vested shares will be delivered to the reporting person upon vesting.
- F3The option is immediately exercisable.
- F4The option is exercisable to 2,544 shares. The option becomes exercisable with respect to the remaining shares in two equal annual installments of 2,544 on September 1, 2018, and 2019.
- F5The option becomes exercisable as to 2,169 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will become exercisable on January 31, 2019.
Remarks
The Power of Attorney given by Mr. Dillon was previously filed with the U.S. Securities & Exchange Commission on September 6, 2016 as an exhibit to a statement on Form 3 filed by Mr. Dillon with respect to HealthEquity, Inc. and is hereby incorporated by reference.